NCT00595699View on ClinicalTrials.gov

Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Major DepressionTemporal Lobe Epilepsy
Interventions
DRUG

escitalopram

10 mg daily for the first week followed by an increase to 20 mg daily for the remainder of the study

DRUG

placebo

Placebo

Trial Locations (1)

70115

LSU Anxiety and Mood Disorders Clinic, New Orleans

Sponsors

Collaborators (1)

Forest Laboratories
All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Conrad, Erich J., M.D.

OTHER